clinical

Videos

Carl Regillo, MD, takes us through the history of the port delivery system, from ideation to FDA approval.

Exploring the history of the port delivery system with Carl Regillo, MD

Articles

Susvimo, previously called the Port Delivery System with ranibizumab, is a first-of-its-kind therapeutic approach for wet AMD and may help people with the disease maintain their vision with as few as two treatments per year.

Genentech’s Susvimo earns FDA approval

Lynda Charters Enoch started her early “eye life” at the Schepens Eye Research Institute, Boston, which ultimately culminated in her current position as an Editor of 

During a presentation at the EURETINA 2021 Virtual Congress, Prof. Ben Burton detailed how dry AMD patients treated with photobiomodulation therapy have seen improvements in best-corrected visual acuity 9 months after treatment. 


LIGHTSITE II: Photobiomodulation a novel therapy for dry AMD

During a presentation at the EURETINA 2021 Virtual Congress, Daniel Jones, PhD, discussed GA and emphasized the need for additional study to gain a better understanding of the burden experienced by patients.

Study targets the burden of geographic atrophy

In a presentation at the EURETINA 2021 Virtual Congress, Cristina Cristian, MD, noted that an injection of brolucizumab treatment in patients with neovascular age-related macular degeneration led to a median improvement in visual acuity (VA) of 10.5 letters and the drug was well-tolerated. 

Brolucizumab injection offers improved vision in neovascular age-related macular degeneration 

Speaking during the EURETINA 2021 Virtual Congress, Marta Belmonte-Grau, MD, discussed the potential risk for posterior capsular rupture during cataract surgery. 

Study targets intravitreal injections for AMD and PCR risks

Investigators find imaging method may be useful to monitor disease progression.

FLIO provides insight into autofluorescence lifetimes in AMD

Novel treatments may be on the horizon for the advanced form of age-related macular degeneration.

Geographic atrophy: A few things to help make sense of a rapidly changing landscape

Cheryl Guttman is a medical writer based in Deerfield, Ill.

Ophthalmologists face challenges of drug delivery for retinal diseases.

The state of retina therapeutics, dissected by international panel

Key takeaways from a discussion on the management of age-related macular degeneration, diabetic macular edema, and inherited retinal disease and insight regarding what to look forward to as the field advances.